HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes

Kate Chatfield-Reed1, Shanying Gui1, Wendi Q O'Neill1

  • 1Seidman Cancer Center, University Hospitals, Cleveland, OH 44106, United States; Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, United States.

Oral Oncology
|December 14, 2019
PubMed
Abstract